Venous Thromboembolism Associated With Pregnancy: JACC Focus Seminar.

@article{Nichols2020VenousTA,
  title={Venous Thromboembolism Associated With Pregnancy: JACC Focus Seminar.},
  author={Katherine M. Nichols and Stanislav Henkin and Mark A. Creager},
  journal={Journal of the American College of Cardiology},
  year={2020},
  volume={76 18},
  pages={
          2128-2141
        }
}
How can Secondary Thromboprophylaxis in High-Risk Pregnant Patients be Improved?
  • L. Stanciakova, M. Dobrotová, J. Staško
  • Medicine
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
  • 2022
TLDR
The results indicate that hemostasis may not be restored even 6 to 8 weeks after delivery and pose the question when is it safe to withdraw the anticoagulant thromboprophylaxis in high-risk patients with prior VTE.
Review article inferior vena cava thrombosis: a case series of patients observed in Taiwan and literature review
TLDR
The first case series of IVCT observed in Taiwan is reported with a brief literature review, and four patients experienced complete IVC thrombosis with bilateral lower extremity swelling and abdominal wall superficial venous dilatation.
Heart disease in women: a narrative review
TLDR
This review will focus on female‐specific characteristics of cardiovascular disease and how these may impact on anaesthetic and peri‐operative risk assessment and care, including those disease entities that are more common in women including sudden coronary artery dissection or microvascular dysfunction.
Acute Coronary Syndrome in Pregnancy and the Post-Partum Period
Cardiovascular disease is the leading cause of maternal mortality in the United States. Acute coronary syndrome (ACS) is more common in pregnant women than in non-pregnant controls and contributes to
Pregnancy and Lower Limb Swelling
...
...

References

SHOWING 1-10 OF 151 REFERENCES
Epidemiology of venous thromboembolism (VTE) associated with pregnancy.
TLDR
The VTE incidence rate in women from developed countries for both antepartum and postpartum periods and for subpopulations of women affected by additional risk factors, such as thrombophilias, circulatory diseases, preeclampsia of varying degrees of severity, and Caesarean section is discussed.
Pregnancy and venous thromboembolism: 'TIPPS' for risk stratification.
  • M. Rodger
  • Medicine
    Hematology. American Society of Hematology. Education Program
  • 2014
TLDR
Risks of VTE must be understood and explored when deciding to prescribe antepartum or postpartum thromboprophylaxis and must be balanced against the downsides of prophylaxis.
Cardiovascular Management in Pregnancy: Antithrombotic Agents and Antiplatelet Agents
TLDR
The use of both older and new anticoagulants and antiplatelet medications during pregnancy are reviewed and their clinical utility in conditions including VTE, thrombophilias, mechanical heart valves, antiphospholipid syndrome (APLS), preeclampsia, intrauterine growth restriction (IUGR), and placental abruption is highlighted.
Deep venous thrombosis in pregnancy: incidence, pathogenesis and endovascular management.
TLDR
Inferior vena cava filter placement and pharmacomechanical catheter directed thrombolysis in the pregnant patient are discussed, as well as patient selection criteria, and complications.
Guidance for the treatment and prevention of obstetric-associated venous thromboembolism
TLDR
Practical clinical guidance on the prevention and treatment of obstetric-associated VTE based on existing guidelines and consensus expert opinion based on available literature where guidelines are lacking is provided.
American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy.
TLDR
These evidence-based guidelines of the American Society of Hematology are intended to support patients, clinicians and others in decisions about the prevention and management of pregnancy-associated VTE.
Recommendations for the diagnosis and treatment of deep venous thrombosis and pulmonary embolism in pregnancy and the postpartum period
TLDR
Recommendations for the diagnosis and management of acute deep venous thrombosis (DVT) and PE are presented and low‐molecular‐weight heparin (LMWH) is the preferred therapy for acute VTE that occur during pregnancy.
Postpartum thromboembolism: Severe events might be preventable using a new risk score model
TLDR
Almost one-half of postpartum VTE cases and 70% of pulmonary emboli cases have at least two large risk factors and might be preventable using the new algorithm, and from the perspective of the health care system the new recommendations appears to be cost-effective.
ACOG Practice Bulletin No. 196: Thromboembolism in Pregnancy.
TLDR
The prevalence and severity of this condition during pregnancy and the peripartum period warrant special consideration of management and therapy, and therapy includes the treatment of acute thromBotic events and prophylaxis for those at increased risk of thrombotic events.
PMM.85 Radiation considerations for catheter directed thrombolysis in iliofemoral thrombosis n pregnancy
TLDR
A 34 year old, 13-week pregnant lady presented with an 8-day history of acute onset painful lower left leg swelling and erythema, which rendered her wheelchair bound and it was thought that the thrombus technically amenable to CDT for relief of disabling symptoms.
...
...